全文获取类型
收费全文 | 34394篇 |
免费 | 2257篇 |
国内免费 | 863篇 |
专业分类
耳鼻咽喉 | 310篇 |
儿科学 | 423篇 |
妇产科学 | 393篇 |
基础医学 | 1573篇 |
口腔科学 | 4137篇 |
临床医学 | 2385篇 |
内科学 | 3793篇 |
皮肤病学 | 400篇 |
神经病学 | 2081篇 |
特种医学 | 380篇 |
外国民族医学 | 1篇 |
外科学 | 1376篇 |
综合类 | 3536篇 |
一般理论 | 3篇 |
预防医学 | 2355篇 |
眼科学 | 163篇 |
药学 | 10588篇 |
13篇 | |
中国医学 | 2091篇 |
肿瘤学 | 1513篇 |
出版年
2024年 | 161篇 |
2023年 | 679篇 |
2022年 | 990篇 |
2021年 | 1347篇 |
2020年 | 1257篇 |
2019年 | 1555篇 |
2018年 | 1636篇 |
2017年 | 1347篇 |
2016年 | 1227篇 |
2015年 | 1150篇 |
2014年 | 2414篇 |
2013年 | 3121篇 |
2012年 | 2057篇 |
2011年 | 2326篇 |
2010年 | 1686篇 |
2009年 | 1538篇 |
2008年 | 1442篇 |
2007年 | 1447篇 |
2006年 | 1164篇 |
2005年 | 1061篇 |
2004年 | 872篇 |
2003年 | 838篇 |
2002年 | 583篇 |
2001年 | 590篇 |
2000年 | 441篇 |
1999年 | 391篇 |
1998年 | 368篇 |
1997年 | 318篇 |
1996年 | 315篇 |
1995年 | 280篇 |
1994年 | 232篇 |
1993年 | 233篇 |
1992年 | 246篇 |
1991年 | 173篇 |
1990年 | 177篇 |
1989年 | 138篇 |
1988年 | 147篇 |
1987年 | 99篇 |
1986年 | 109篇 |
1985年 | 236篇 |
1984年 | 185篇 |
1983年 | 130篇 |
1982年 | 142篇 |
1981年 | 90篇 |
1980年 | 93篇 |
1979年 | 75篇 |
1978年 | 81篇 |
1977年 | 68篇 |
1976年 | 58篇 |
1975年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Nonpigmenting fixed exanthema from ephedrine and pseudoephedrine 总被引:2,自引:2,他引:0
102.
P C G?tzsche 《Journal of clinical epidemiology》1990,43(12):1313-1318
In a meta-analysis of placebo controlled NSAID trials, the sensitivity of the effect variables was calculated as the correlation coefficient and as the difference between drug and placebo, divided by the placebo group standard deviation. The patient's global evaluation was the most sensitive variable overall. Pain was more sensitive than Ritchie's index. Several variables may be omitted from clinical trials, especially if two active drugs are being compared. For example, the best maximum estimate for the difference in ESR between NSAADs and placebo was 1.0 mm/hr (95% confidence interval −1.5 to 3.4 mm/hr), and for joint size 0.44% (−1.0 to 1.9%), corresponding to a quarter of a millimeter for each of the 10 joints usually measured. It is suggested to record only the patient's global evaluation, pain, and morning stiffness. 相似文献
103.
104.
Abstract: Elevated lipoprotein concentrations seem to be linked strongly in a dose dependent manner to an increased incidence of atherosclerosis. A total of 47 patients suffering from severe hyperlipidemia were matched to treatment with LDL apheresis (Baxter, Kaneka, Li–popak; 24 patients, aged 50.2 ±11.5 years), diet, and/or lipid–lowering drugs or with diet and lipid–lowering drugs only (23 patients, aged 48.8 ±11.8 years). After treatment periods of 49.8 ±13.4 months (apheresis group, 2,396 treatment sessions) and 38.6 ± 15.1 months (drug group), the ensuing results revealed significant differences (p <0.0001): –47.3% versus –12.1% for total cholesterol, –46.9% versus –21.8% for LDL, +8.4% versus +0.9% for HDL, –52.0% versus – 13.1% for the LDL/HDL ratio, –36.4% versus –16.2% for triglycerides, and –25.9% versus + 1.5% for lipoprotein (a). In the apheresis group, one patient died of myocardial infarction; in the drug group, there was one nonfatal myocardial infarction and the manifestation of coronary heart disease in 3 cases. There were no severe side effects in either group. All patients in the apheresis group responded to therapy. The present trial suggests that a continuing reduction in serum lipid concentrations may lower, in a dose dependent manner, the risk for development and progression of coronary heart disease. Regarding clinical and laboratory results, LDL apheresis seems to be safe, effective therapy for treatment of severe hyperlipidemia. 相似文献
105.
Nobuyuki Tanaka Yutaka Kimijima Masafumi Mimura Akira Yamaguchi Shizuko Ichinose Gen-iku Kohama Masaaki Satoh 《Medical Electron Microscopy》1998,31(3):156-161
A rare case of lentigo maligna in the oral cavity was investigated by light and electron microscopy. Cutaneous lentigo malignas often develop to malignant melanomas. However, the electron microscopic examination revealed that even though there were a large number of melanosomes, most of them were late stage and had membrane structure, and positive staining with HMB-45 was not recognized. From our findings, it is difficult to conclude that oral lentigo malignas develop malignant melanomas, and thus further studies are needed. 相似文献
106.
采用大肠菌群作为卫生指示菌,对口服药品进行细菌学检验,实验结果表明有利于口服药品染菌状况的监督与控制。 相似文献
107.
Allen Cato III Linda E. Gustavson Jiang Qian Tawakol El-Shourbagy Edward A. Kelly 《Epilepsia》1998,39(1):43-47
Summary: Purpose: We wished to determine the effect of renal impairment on the pharmacokinetics and tolerability of the new antiepileptic drug tiagabine (TGB).
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
108.
H. GR
NNEBECH G. JOHANSSON M. SMEDEB
L N. VALENTIN 《Acta anaesthesiologica Scandinavica》1993,37(5):454-457
As glycopyrrolate has been reported superior to atropine with respect to reduction of salivation, stability of cardiac rate and rhythm, and recovery, a comparison of these properties of the two drugs and placebo was made in 45 patients undergoing direct laryngoscopy and 45 patients undergoing bronchoscopy, in most cases followed by mediastinoscopy. When given i.m. 30 min before anaesthesia (midazolam, alfentanil, thiopentone, and suxamethonium), the two test drugs were found to be equally potent regarding the antisialogogic effect. The same increase in heart rate after the test drugs was seen before induction, and during anaesthesia heart rate rose to the same level in the placebo group as the test groups. During anaesthesia, blood pressure was lowest in the atropine group. No differences could be demonstrated with respect to cardiac arrhythmias, possibly due to the small size of the material. The present study gives no reason for preferring either drug, and only the efficacy of both test drugs in controlling airway secretions provides an argument for using any anticholinergic drug when laryngoscopy or bronchoscopy is performed under the conditions of the present study. 相似文献
109.
通过对金锁匙口服液的药效学及毒性的研究表明:本品能明显抑制吗啡依赖性小白鼠停药后的跳跃反应,协同戊巴比妥钠催眠作用,提高小鼠热板法痛阈值,抑制醋酸引起的小鼠扭体反应,提示金锁匙口服液对吗啡类成瘾患者有一定的治疗作用,毒理研究表明;本品服用无药物依赖性、安全、无毒。 相似文献
110.
Grimbizis G.; Tarlatzis B.C.; Bontis J.; Miliaras D.; Lagos S.; Pournaropoulos F.; Mantalenakis S. 《Human reproduction (Oxford, England)》1995,10(3):520-523
Concerns have been raised recently about the possible associationbetween superovulation and ovarian cancer. In order to contributeto the limited literature on this important issue, two casesof ovarian tumours in women who had undergone multiple ovulationinductions are presented. In the first case, the patient hadsecondary anovulatory infertility. She was treated with humanmenopausal gonadotrophin (HMG) alone and in combination withclomiphene citrate or buserelin for six cycles. She then underwentovarian stimulation with buserelin/HMG in the long protocolfor in-vitro fertilization (IVF) and embryo transfer. In preparationfor a new IVF/embryo transfer attempt, 8 months later, the screeningultrasound revealed a cystic formation of the left ovary andan enlargement of the right. During laparotomy, both ovarieswere found to bear large tumours (approximately 6x5x4 cm) whichwere removed. Histological examination showed that they wereepithelial tumours (serous-papillary cystadenomas) of borderlinemalignancy. The patient conceived spontaneously 1.5 years afterthe operation. In the second case, the patient presented withsecondary anovulatory infertility. She underwent ovulation inductionwith clomiphene/HMG and with buserelin/HMG in the long protocol,and intra-uterine insemination with husband's spermatozoa andconceived (singleton pregnancy). She was delivered by Caesareansection, during which a cystic tumour of the left ovary wasremoved. Histological examination revealed a benign mucous cystadenomaof the ovary. In conclusion, the clinical information from thesetwo cases does not support a causal association between ovarianstimulation and ovarian tumours but does potntially supporta facilitating one. 相似文献